Leptin receptor action and mechanisms of leptin resistance

Cellular and Molecular Life Sciences

Volumn 62, Issue 6, 2005, Pages 642-652

  Munzberg H ^a   Bjornholm M ^a   Bates, S H ^a   Myers Jr , M G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Arcuate nucleus; Hypothalamus; Leptin; Obesity; Signaling; SOCS3

Indexed keywords

ANOREXIGENIC AGENT; LEPTIN; LEPTIN RECEPTOR;

BRAIN; DRUG MECHANISM; EATING DISORDER; ENDOCRINE DISEASE; HUMAN; HYPERPHAGIA; HYPOTHALAMUS; NERVE CELL NETWORK; NONHUMAN; OBESITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; DNA-BINDING PROTEINS; ENERGY METABOLISM; HUMANS; HYPOTHALAMUS; LEPTIN; NERVE NET; OBESITY; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 17044370492     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4432-1     Document Type: Review

References (115)

1. Friedman J. M. and Halaas J. L. (1998) Leptin and the regulation of body weight in mammals. Nature 395: 763-770
2. Elmquist J. K., Maratos-Flier E., Saper C. B. and Flier J. S. (1998) Unraveling the central nervous system pathways underlying responses to leptin. Nature Neurosci. 1: 445-149
3. Bates S. H. and Myers M. G. Jr (2003) The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol. Metab. 14: 447-452
4. Kennedy G. C. (1953) The role of depot fat in the hypothalamic control of food intake in rats. Proc. R. Soc. 140: 578-592
5. Ahima R. S., Prabakaran D., Mantzoros C. S., Qu D., Lowell B. B., Maratos-Flier E. et al. (1996) Role of leptin in the neuroendocrine response to fasting. Nature 382: 250-252
6. Lord G. M., Matarese G., Howard J. K., Baker R. J., Bloom S. R. and Lechler R. I. (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901
7. Montague C. T., Farooqi I. S., Whitehead J. P., Soos M. S., Rau H, Wareham N. J. et al. (1997) Congenital leptin deficiency is associated with severe early onset obesity in humans. Nature 387: 903-908
8. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D. et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392: 398-401
9. Tartaglia L. A. (1997) The leptin receptor. J. Biol. Chem. 272: 6093-6096
10. Chua S. C. Jr, Kontras I. K., Han L., Liu S. M., Kay J., Young S. J. et al. (1997) Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. Genomics 45: 264-270
11. Ge H., Huang L., Pourbahrami T. and Li C. (2002) Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J Biol Chem 277: 45898-45903
12. Elmquist J. K., Elias C. F. and Saper C. B. (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22: 221-232
13. Elmquist J. K., Bjorbaek C., Ahinia R. S., Flier J. S. and Saper C. B. (1998) Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 395: 535-547
14. Baskin D. G., Schwartz M. W., Seeley R. J., Woods S. C., Porte D. Jr, Breininger J. F. et al. (1999) Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. J. Histochem. Cytochem. 47: 353-362
15. Schwartz M. W., Woods S. C., Porte D. Jr, Seeley R. J. and Baskin D. G. (2000) Central nervous system control of food intake. Nature 404: 661-671
16. Inui A. (1999) Feeding and body-weight regulation by hypothalamic neuropeptides - mediation of the actions of leptin. Trends Neurosci. 22: 62-67
17. Huo L., Munzberg H., Nillni E. A. and Bjorbaek C. (2004) Role of signal transducer and activator of transcription 3 in regulation of hypothalamic trh gene expression by leptin. Endocrinology 145: 2516-2523
18. Elmquist J. K., Ahima R. S., Maratos-Flier E., Flier J. S. and Saper C. B. (1997) Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 138: 839-842
19. Liu L., Karkanias G. B., Morales J. C., Hawkins M., Barzilai N., Wang J. et al. (1998) Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J. Biol. Chem. 273: 31160-31167
20. Kulkarni R. N., Wang Z. L., Wang R. M., Hurley J. D., Smith D. M., Ghatei M. A. et al. (1997) Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J. Clin. Invest. 100: 2729-2736
21. Burcelin R., Kamohara S., Li J., Tannenbaum G. S., Charron M. J. and Friedman J. M. (1999) Acute intravenuous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 48: 1264-1269
22. + channels in pancreatic beta-cells. Diabetes 46: 1087-1093
23. Huszar D., Lynch C. A., Fairchild-Huntress V., Dumnore, J. H., Fang Q., Berkemeier L. R. et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141
24. Butler A. A. and Cone R. D. (2002) The melanocortin receptors: lessons from knockout models. Neuropeptides 36: 77-84
25. Marsh D. J., Hollopeter G., Huszar D., Laufer R., Yagaloff K. A., Fisher, S. L. et al. (1999) Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21: 119-122
26. Ste Marie L., Miura G. I., Marsh D. J., Yagaloff K. and Palmiter R. D. (2000) A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc. Natl. Acad. Sci. USA 97: 12339-12344
27. Butler A. A., Kesterson R. A., Khong K., Cullen M. J., Pelleymounter M. A., Dekoning J. et al. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141: 3518-3521
28. Chen A. S., Marsh D. J., Trumbauer M. E., Frazier E. G., Guan X. M., Yu H. et al. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26: 97-102
29. Cowley M. A., Smart J. L., Rubinstein M., Cerdan M. G., Diano S., Horvath T. L. et al. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484
30. Wren A. M., Small C. J., Abbott C. R., Dhillo W. S., Seal L. J., Cohen M. A. et al. (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50: 2540-2547
31. Chen H. Y., Trumbauer M. E., Chen A. S., Weingarth D. T., Adams J. R., Frazier E. G. et al. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145: 2607-2612
32. Qian S., Chen H., Weingarth D., Trumbauer M. E., Novi D. E., Guan X. et al. (2002) Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol. 22: 5027-5035
33. Erickson J. C., Hollopeter G. and Palmiter R. D. (1996) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274: 1704-1707
34. Sindelar D. K., Mystkowski P., Marsh D. J., Palmiter R. D. and Schwartz M. W. (2002) Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice. Diabetes 51: 778-783
35. MacNeil D. J., Howard A. D., Guan X., Fong T. M., Nargund R. P., Bednarek M. A. et al. (2002) The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur. J. Pharmacol. 450: 93-109
36. Balthasar N., Coppari R., McMinn J., Liu S. M., Lee C. E., Tang V. et al. (2004) Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42: 983-991
37. Munzberg H., Huo L., Nilini E. A., Hollenberg A. N. and Bjorbaek C. (2003) Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 144: 2121-2131
38. Taga T. and Kishinioto T. (1997) gp130 and the interleukin-6 family of cytokines. Ann. Rev. Immunol. 15: 797-819
39. Ihle J. N. and Kerr I. M. (1995) Jaks and Stats in signaling by the cytokine receptor superfamily. TIG 11: 69-74
40. Taniguchi T. (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268: 251-255
41. Kloek C., Haq A. K., Dunn S. L., Lavery H. J., Banks A. S. and Myers M. G. Jr (2002) Regulation of Jak kinases by intracellular leptin receptor sequences. J. Biol. Chem. 277: 41547-41555
42. Devos R., Guisez Y., Van der Heyden J., White D. W., Kalai M., Fountoulakis M. et al. (1997) Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding. J. Biol. Chem. 272: 18304-18310
43. Couturier C. and Jockers R. (2003) Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers. J. Biol. Chem. 287: 26604-26611
44. White D. W., Kuropatwinski K. K., Devos R., Baumann H. and Tartaglia, L. A. (1997) Leptin receptor (OB-R) signaling. J. Biol. Chem. 272: 4065-4071
45. Banks A. S., Davis S. M., Bates S. H. and Myers M. G. Jr (2000) Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275: 14563-14572
46. Bahrenberg G., Behrmann I., Barthel A., Hekerman P., Heinrich P. C., Joost H. G. et al. (2002) Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Mol. Endocrinol. 16: 859-872
47. Koch C. A., Anderson D. J., Moran M. F., Ellis C. A. and Pawson T. (1991) SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252: 668-674
48. Songyang Z., Shoelson S. E., Chaudhuri M., Gish G. D., Pawson T., Haser W. G. et al. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778
49. Haan S., Hemmann U., Hassiepen U., Schaper F., Schneider-Mergener J., Wollmer A. et al. (1999) Characterization and binding specificity of the monomeric STAT3-SH2 domain. J. Biol. Chem. 274: 1342-1348
50. Bjorbaek C., Buchholz R. M., Davis S. M., Bates S. H., Pierroz D. D., Gu H. et al. (2001) Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 276: 4747-4755
51. Bjorbaek C., Elmquist J. K, Frantz J. D., Shoelson S. E. and Flier J. S. (1998) Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell. 1: 619-625
52. Bjorbaek C., Lavery H. J., Bates S. H., Olson R. K., Davis S. M., Flier J. S. et al. (2000) SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275: 40649-40657
53. Sasaki A., Yasukawa H., Shouda T., Kitamura T., Dikic I. and Yoshimura A. (2000) CIS3/SOCS3 suppresses erythropoietin signaling by binding the EPO receptor and JAK2. J. Biol. Chem. 275: 29338-29347
54. Sasaki A., Yasukawa H., Suzuki A., Kamizono S., Syoda T., Kinjyo I. et al. (1999) Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4: 339-351
55. 1007 in the kinase activation loop. Mol. Cell. Biol. 17: 2497-2501
56. Carpino N., Kobayashi R., Zang H., Takahashi Y., Jou S. T., Feng J. et al. (2002) Identification, cDNA cloning and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein. Mol. Cell. Biol. 22: 7491-7500
57. Argetsinger L. S., Kouadio J. L., Steen H., Stensballe A., Jensen O. N. and Carter-Su C. (2004) Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Mol. Cell. Biol. 24: 4955-4967
58. Feener E. P., Rosario F., Dunn S. L., Stancheva Z. and Myers M. G. Jr (2004) Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling. Mol. Cell. Biol. 24: 4968-4978
59. Kurzer J. H., Argetsinger L. S., Zhou Y. J., Kouadio J. L., O'Shea J. J. and Carter-Su C. (2004) Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. Mol. Cell. Biol. 24: 4557-4570
60. Niswender K. D., Morton G. J., Stearns W. H., Rhodes C. J., Myers M. G. Jr and Schwartz. M. W. (2001) Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413: 794-795
61. Niswender K. D., Morrison C. D., Clegg D. J., Olson R., Baskin D. G., Myers M. G. Jr et al. (2003) Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52: 227-231
62. Argetsinger L. S., Hsu G. W., Myers, M. G. Jr, Billestrup N., White M. F. and Carter-Su C. (1995) Growth hormone, interferon-γ and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270: 14685-14692
63. Carvalheira J. B., Ribeiro E. B., Araujo E. P., Guimaraes R. B., Telles M. M., Torsoni M. et al. (2003) Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 46: 1629-1640
64. Carvalheira J. B., Siloto R. M., Ignacchitti I., Brenelli S. L., Carvalho C. R., Leite A. et al. (2001) Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. Growth Regul. 500: 119-124
65. Myers M. G. Jr and White M. F. (2002) The molecular basis of insulin action. 4: 712-727
66. Withers D. J., Gutierrez J. S., Towery H., Burks D. J., Ren J. M., Previs S. et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904
67. Burks D. J., de Mora J. F., Schubert M., Withers D. J., Myers M. G. Jr, Towery H. H. et al. (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407: 377-382
68. Araki E., Lipes M. A., Patti M. E., Brüning J. C., Haag B. L. III, Johnson R. S. et al. (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190
69. Spanswick D., Smith M. A., Groppi V. E., Logan S. D. and Ashford M. L. (1997) Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390: 521-525
70. Harvey J., McKay N. G., Walker K. S., Van der Kaay J., Downes C. P. and Ashford M. L. (2000) Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line. J. Biol. Chem. 275: 4660-4669
71. Rahmouni K., Haynes W. G., Morgan D. A. and Mark A. L. (2003) Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 41: 763-767
72. Bates S. H., Stearns W. H., Schubert M., Tso A. W. K., Wang Y., Banks A. S. et al. (2003) STAT3 signaling is required for leptin regulation of energy balance but not reproduction. Nature 421: 856-859
73. Schweizer U., Gunnersen J., Karch C., Wiese S., Holtmann B., Takeda K. et al. (2002) Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J. Cell. Biol. 156: 287-297
74. Bates S. H., Dundon T. A., Seifert M., Carlson M., Maratos-Flier E. and Myers M. G. Jr (2004) LRb-STAT3 signaling is required for the neuroendocrine control of energy expenditure by leptin. Diabetes 53: 3067-3073
75. Guo F., Bakal K., Minokoshi Y. and Hollenberg A. N. (2004) Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology 145: 2221-2227
76. Legradi G. and Lechan R. M. (1998) The arcuate nucleus is the major source for neuropeptide Y-innervation of thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 139: 3262-3270
77. Fekete C., Legradi G., Mihaly E., Huang Q. H., Tatro J. B., Rand W. M. et al. (2000) alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J. Neurosci. 20: 1550-1558
78. Mihaly E., Fekete C., Tatro J. B., Liposits Z., Stopa E. G. and Lechan R. M. (2000) Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J. Clin. Endocrinol. Metab 85: 2596-2603
79. Spanswick D., Smith M. A., Groppi V. E., Logan S. D. and Ashford M. (1997) Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390: 521-525
80. Roth J. (1998) Diabetes and obesity. Diab. Met. Rev. 13: 1-2
81. Farooqi I. S., Jebb S. A., Langmack G., Lawrence E., Cheetham C. H., Prentice A. M. et al. (1999) Effects of reconibinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341: 879-884
82. Fogteloo A. J., Pijl H., Frolich M., McCamish M. and Meinders A. E. (2003) Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutr. Metab 16: 109-114
83. Licinio J., Caglayan S., Ozata M., Yildiz B. O., de Miranda P. B., O'Kirwan F. et al. (2004) Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc. Natl. Acad. Sci. USA 101: 4531-4536
84. McDuffie J. R., Riggs P. A., Calis K. A., Freedman, R. J., Oral E. A., Depaoli A. M. et al. (2004) Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency. J. Clin. Endocrinol. Metab. 89: 4258-4263
85. Oral E. A., Simlia V., Ruiz E., Andewelt A., Premkumar A., Snell, P. et al. (2002) Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346: 570-578
86. Shimomura L. Hammer R. E., Ikemoto S., Brown M. S. and Goldstein J. L. (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy [In Process Citation]. Nature 401: 73-76
87. Welt C. K., Chan J. L., Bullen J., Murphy R., Smith P., Depaoli A. M. et al. (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N. Engl. J. Med. 351: 987-997
88. Chan J. L., Heist K., Depaoli A. M., Veldhuis J. D. and Mantzoros C. S. (2003) The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J. Clin. Invest. 111: 1409-1421
89. Fogteloo J., Meinders E., Frolich M., McCamish M. and Pijl H. (2003) The decline in plasma leptin in response to calorie restriction predicts the effects of adjunctive leptin treatment on body weight in humans. Eur. J. Intern. Med. 14: 415-418
90. Hukshorn C. J., Westerterp-Plantenga M. S. and Saris W. H. (2003) Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted, overweight men. Am. J. Clin. Nutr. 77: 771-776
91. Rosenbaum M., Murphy E. M., Heymsfield S. B., Matthews D. E. and Leibel R. L. (2002) Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J. Clin. Endocrinol. Metab. 87: 2391-2394
92. Westerterp-Plantenga M. S., Saris W. H., Hukshom C. J. and Campfield L. A. (2001) Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am. J. Clin. Nutr. 74: 426-434
93. Tups A., Ellis C., Moar K. M., Logie T. J., Adam C. L., Mercer J. G. et al. (2004) Photoperiodic regulation of leptin sensitivity in the Siberian hamster, Phodopus simgorus, is reflected in arcuate nucleus SOCS-3 (suppressor of cytokine signaling) gene expression. Endocrinology 145: 1185-1193
94. Ladyman S. R. and Grattan D. R. (2004) Region-specific reduction in leptin-induced phosphorylation of signal transducer and activator of transcription-3 (STAT3) in the rat hypothalamus is associated with leptin resistance during pregnancy. Endocrinology 145: 3704-3711
95. Howard J. K., Cave B. J., Oksanen L. J., Tzameli I., Bjorbaek C. and Flier J. S. (2004) Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10: 734-738
96. Banks W. A. (2004) The many lives of leptin. Peptides 25: 331-338
97. Kastin A. J., Pan W., Maness L. M., Koletsky R. J. and Ernsberger P. (1999) Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 20: 1449-1453
98. Maness L. M., Banks W. A. and KastinA. J. (2000) Persistence of blood-to-brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice. Brain Res. 873: 165-167
99. Levin B. E., Dunn-Meynell A. A. and Banks W. A. (2004) Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am. J. Physiol Regul. Integr. Comp Physiol 286: R143-R150
100. El Haschimi K., Pierroz D. D., Hileman S. M., Bjorbaek C. and Flier J. S. (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest 105: 1827-1832
101. Zabolotny J. M., Bence-Hanulec K. K., Stricker-Krongrad A., Haj F., Wang Y., Minokoshi Y. et al. (2002) PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2: 489-495
102. Cheng A., Uetani N., Simoncic P. D., Chaubey V. P., Lee-Loy A., McGlade C. J. et al. (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell 2: 497-503
103. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins, S., Loy A. L. et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1b gene. Science 283: 1544-1548
104. Bjorbaek C., El Haschimi K., Frantz J. D. and Flier J. S. (1999) The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274: 30059-30065
105. Mori H., Hanada R., Hanada T., Aki D., Mashima R., Nishinakamura H. et al. (2004) Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10: 739-743
106. Kimura A., Kinjyo I., Matsumura Y., Mori H., Mashima R., Harada M. et al. (2004) SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J. Biol Chem. 279: 6905-6910
107. Croker B. A., Krebs D. L., Zhang J. G., Wormald S., Willson T. A., Stanley E. G. et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol 4: 540-545
108. Takahashi Y., Carpino N., Cross J. C., Torres M., Parganas E. and Ihle J. N. (2003) SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J 22: 372-384
109. Marine J. C., McKay C., Wang D., Topham D. J., Parganas E., Nakajima H. et al. (1999) SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 98: 617-627
110. Munzberg H., Flier J. S. and Bjorbaek C. (2004) Region-Specific Leptin Resistance within the Hypothalamus of Diet-Induced - Obese Mice. Endocrinology 145: 4880-4889
111. Correia M. L., Haynes W. G., Rahmouni K., Morgan D. A., Sivitz W. I. and Mark A. L. (2002) The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51: 439-442
112. Krisch B. and Leonhardt H. (1978) The functional and structural border of the neurohemal region of the median eminence. Cell Tissue Res. 192: 327-339
113. Johnson A. K. and Gross P. M. (1993) Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 7: 678-686
114. Hu L., Fernstrom J. D. and Goldsmith P. C. (1998) Exogenous glutamate enhances glutamate receptor subunit expression during selective neuronal injury in the ventral arcuate nucleus of postnatal mice. Neuroendocrinology 68: 77-88
115. Peruzzo B., Pastor F. E., Blazquez J. L., Schobitz K., Pelaez B., Amat P. et al. (2000) A second look at the barriers of the medial basal hypothalamus. Exp. Brain Res. 132: 10-26